CEP905321 Supplemental Material1 - Supplemental material for Phase 3 randomized, placebo-controlled study of galcanezumab in patients with chronic cluster headache: Results from 3-month double-blind treatment
- Resource Type
- Source
- Subject
FOS: Psychology FOS: Clinical medicine 170199 Psychology not elsewhere classified 110319 Psychiatry (incl. Psychotherapy) 110306 Endocrinology 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 110904 Neurology and Neuromuscular Diseases Neuroscience - Language